Comparative Study between Shortened versus Standard Protocols of Postpartum Magnesium Sulphate Regimen in the Treatment of Eclampsia  

作　　者：Nermeen Mohamed Hefila Tamer Mamdouh Abdeldayem Nermeen Mohamed Hefila;Tamer Mamdouh Abdeldayem(Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University, Alexandria, Egypt)

机构地区：[1]Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University, Alexandria, Egypt

出　　处：《Open Journal of Obstetrics and Gynecology》2021年第8期935-939,共5页妇产科期刊（英文）

摘　　要：Eclampsia is one of the most <span style="font-family:Verdana;">sever</span><span style="font-family:Verdana;">, </span><span style="font-family:Verdana;">life</span><span style="font-family:Verdana;">-</span><span style="font-family:Verdana;">threatening</span><span style="font-family:""><span style="font-family:Verdana;"> diseases </span><span style="font-family:Verdana;">occurred</span><span style="font-family:Verdana;"> in pregnancy, MgSO</span>_{<span style="font-family:Verdana;">4</span>}<span style="font-family:Verdana;"> is the best drug used for its treatment. In this study, </span></span><span style="font-family:Verdana;">the </span><span style="font-family:Verdana;">comparison</span><span style="font-family:""><span style="font-family:Verdana;"> between shortened </span><span style="font-family:Verdana;">regimen</span><span style="font-family:Verdana;"> of MgSO</span>_{<span style="font-family:Verdana;">4</span>}<span style="font-family:Verdana;"> versus standard Zuspan </span><span style="font-family:Verdana;">course</span><span style="font-family:Verdana;"> in controlling eclampsia was done</span><i><span style="font-family:Verdana;">. </span></i><span style="font-family:Verdana;">This study </span><span style="font-family:Verdana;">performed</span> <span style="font-family:Verdana;">along</span><span style="font-family:Verdana;"> one year (July 2019-July 2020) at El Shatby Maternity University Hospital, 40 eclamptic patients presenting at the emergency unit were randomized. Group A received the standard Zuspan regimen of magnesium </span><span style="font-family:Verdana;">sulphate</span><span style="font-family:Verdana;"> and group B </span><span style="font-family:Verdana;">received</span> <span style="font-family:Verdana;">short</span><span style="font-family:Verdana;"> course in which the patients </span><span style="font-family:Verdana;">received</span><span style="font-family:Verdana;"> only two doses of intravenous magnesium </span><span style="font-family:Verdana;">sulphate</sEclampsia is one of the most <span style="font-family:Verdana;">sever</span><span style="font-family:Verdana;">, </span><span style="font-family:Verdana;">life</span><span style="font-family:Verdana;">-</span><span style="font-family:Verdana;">threatening</span><span style="font-family:""><span style="font-family:Verdana;"> diseases </span><span style="font-family:Verdana;">occurred</span><span style="font-family:Verdana;"> in pregnancy, MgSO</span>_{<span style="font-family:Verdana;">4</span>}<span style="font-family:Verdana;"> is the best drug used for its treatment. In this study, </span></span><span style="font-family:Verdana;">the </span><span style="font-family:Verdana;">comparison</span><span style="font-family:""><span style="font-family:Verdana;"> between shortened </span><span style="font-family:Verdana;">regimen</span><span style="font-family:Verdana;"> of MgSO</span>_{<span style="font-family:Verdana;">4</span>}<span style="font-family:Verdana;"> versus standard Zuspan </span><span style="font-family:Verdana;">course</span><span style="font-family:Verdana;"> in controlling eclampsia was done</span><i><span style="font-family:Verdana;">. </span></i><span style="font-family:Verdana;">This study </span><span style="font-family:Verdana;">performed</span> <span style="font-family:Verdana;">along</span><span style="font-family:Verdana;"> one year (July 2019-July 2020) at El Shatby Maternity University Hospital, 40 eclamptic patients presenting at the emergency unit were randomized. Group A received the standard Zuspan regimen of magnesium </span><span style="font-family:Verdana;">sulphate</span><span style="font-family:Verdana;"> and group B </span><span style="font-family:Verdana;">received</span> <span style="font-family:Verdana;">short</span><span style="font-family:Verdana;"> course in which the patients </span><span style="font-family:Verdana;">received</span><span style="font-family:Verdana;"> only two doses of intravenous magnesium </span><span style="font-family:Verdana;">sulphate</s

关 键 词：MgSO₄ ECLAMPSIA MgSO₄ Protocols 

分 类 号：O17[理学—数学]